anayamalik, Author at European Medical Journal - Page 44 of 128

Injections of Blood Plasma Speed Ulcer Recovery in Diabetes

Platelet-rich plasma (PRP) therapy significantly enhances the healing of diabetic foot ulcers compared with standard wound care, according to findings from a randomized controlled trial that assessed both clinical outcomes and histopathological changes.

Familiar Surgical Teams Improve Urologic Cancer Outcomes

Greater familiarity among surgical teams significantly improves outcomes in renal, bladder, and prostate cancer procedures, according to a new study assessing team membership and cohesion.

Disease Clusters in Midlife Strongly Predict Stroke Risk

Midlife health profiles defined by clusters of coexisting conditions significantly influence ischemic stroke incidence and severity, according to a large analysis of participants in the Atherosclerosis Risk in Communities (ARIC) study.

Corticosteroid Use in Asthmatic Children Raises Fracture Risk

Children with asthma face a heightened risk of fractures, particularly when treated with corticosteroids, according to findings from a large nationwide cohort study.

Rare Bacterium Identified in Recurrent Breast Abscess

A rare gram-positive bacterium, Lawsonella clevelandensis, has been identified as the cause of a recurrent breast abscess in a middle-aged woman, underscoring the importance of molecular diagnostics for accurate identification of difficult-to-culture pathogens.

Salivary Ultrasound Adds Value in Sjögren’s Diagnosis

Salivary gland ultrasound (SGUS) demonstrated meaningful diagnostic value for patients with highly suspected Sjögren’s Disease (SjD), particularly when combined with established serological or biopsy measures, according to findings from a prospective monocentric study.

Scalp Micropigmentation Shows Strong Results in Alopecia

Scalp micropigmentation (SMP) demonstrated effective and safe cosmetic improvement for patients with localized alopecia, according to a technical analysis and case series.

TAR-200 Shows Strong Responses in High-Risk Bladder Cancer

TAR-200, an investigational intravesical drug-releasing system delivering sustained gemcitabine, demonstrated high response rates and durable outcomes in patients with bacillus Calmette-Guérin (BCG)–unresponsive high-risk non–muscle-invasive bladder cancer (NMIBC), according to results from the Phase IIb SunRISe-1 study.

Females with PTSD Show Working Memory Deficits

Females with posttraumatic stress disorder showed reduced non-emotional working memory capacity and slower responses on the N-back task, with 2-back slowing linked to greater avoidance and overall symptom severity.

Latest Insights on GLP-1 Therapy for Sleep Apnea

GLP-1 receptor agonists (GLP-1RA) are emerging as a potential therapeutic option for patients with obstructive sleep apnea (OSA), according to a recent review that examined growing clinical evidence.